In the present study, we found that ERCs could significantly inhibit the enhancing immunity function of CD4+ T cells both in vitro and in Con A-induced hepatitis response, while there was an apparent recovery when CD73 was knocked out on ERCs. The gene discussed is CD4; the disease is hepatitis A virus infection.